172 lines
No EOL
4.2 KiB
Markdown
172 lines
No EOL
4.2 KiB
Markdown
NATIONAL SECURITY AGENCY
|
|
UNITED STATES OF AMERICA
|
|
|
|
CENTRAL SECURITY SERVICE
|
|
UNITED STATES OF AMERICA
|
|
|
|
SIGNALS INTELLIGENCE
|
|
SI
|
|
DIRECTORATE
|
|
|
|
UNCLASSIFIED//FOUO
|
|
|
|
# Medical Pattern of Life
|
|
## Targeting High Value Individual #1
|
|
## (SIGINT Enabling HUMINT / Targeting)
|
|
|
|
SIGINT Development Conference
|
|
June 2010
|
|
|
|
Dr. [REDACTED], SSG13, Clinical Psychologist to Operations
|
|
[REDACTED], SSG13, Senior Technical Development Program
|
|
|
|
UNCLASSIFIED//FOUO
|
|
|
|
---
|
|
|
|
TOP SECRET//COMINT//REL
|
|
|
|
## (U) Outline
|
|
|
|
* (U) Project Description
|
|
* (U) Definition of Medical Pattern of Life(POL)
|
|
* (S//SI//REL) Advantages of Medical Intel over Conventional Intel in Prosecuting HVI's.
|
|
* (TS//SI//REL) UBL Medical SIGINT Amplified by HUMINT
|
|
* (TS//REL) Medical Profile for HVI#1
|
|
* New Intelligence + Extrapolated
|
|
* (FOUO) Planned Modus Operandi
|
|
* (FOUO) Technical Solution to Enable Operation
|
|
|
|
TOP SECRET//COMINT//REL
|
|
|
|
---
|
|
|
|
TOP SECRET//COMINT//REL
|
|
|
|
## (C//REL) Medical Intelligence
|
|
|
|
* (C//REL) What is Medical Intelligence?
|
|
* (S//SI//REL) Methodology used for Extracting Medical Pattern of Life (PoL) from Medical Intelligence.
|
|
* (TS//SI//REL) Medical PoL → Identification of all recurring, and therefore predictable, patterns of behavior that constitute the specific treatment regimen for a target's medical illness
|
|
* Medications, Medical Tests, Medical Surgical Treatments, Hospital and Doctor Visits
|
|
|
|
TOP SECRET//COMINT//REL
|
|
|
|
---
|
|
|
|
TOP SECRET//COMINT//REL
|
|
|
|
## (S//REL) High Value Individual Targeting
|
|
|
|
* (TS//SI//REL) Advantages of Medical Intel:
|
|
* Credible Medical Intel Never Goes Stale
|
|
* Tagging and tracking medications/supplies to a specific target enables us to leap over the non-electronic moat with which HVI's surround themselves, enabling their geolocation.
|
|
* Enables Geolocation in Cities or Countryside.
|
|
* (S//REL) Case Examples of the use of Medical PoL for GeoLocation Targets.
|
|
|
|
TOP SECRET//COMINT//REL
|
|
|
|
---
|
|
|
|
TOP SECRET//COMINT//REL
|
|
|
|
## (FOUO) Medical Profile
|
|
|
|
* (TS//SI//REL) Description of UBL Medical PoL
|
|
* (TS//SI//REL) SIGINT Reporting on UBL
|
|
* Doctor in Theater, 2000
|
|
* (TS//SI//REL) CIA Reports
|
|
* "Middle Stage Renal Disease”
|
|
* Recurrent Urinary Tract Infections and Kidney Stones
|
|
* Intestinal Problems
|
|
|
|
TOP SECRET//COMINT//REL
|
|
|
|
---
|
|
|
|
TOP SECRET//COMINT//REL
|
|
|
|
## (U) Project Planning
|
|
|
|
* (S//REL) Acquire Support from Stakeholders
|
|
* British (GCHQ, SIS)
|
|
* US (RX, LPS, Sandia, ORNL, NSA CT, CIA CT)
|
|
* (FOUO) Technical Solution Trade Study
|
|
* (S//REL) Determine Medical Treatment Signature
|
|
* (S//REL) Determine Likely Meds/Equipment
|
|
* (TS//SI//REL) Focus Tag Effort: Supply Chain to HVI
|
|
* Suppliers, ICRC Hospitals, Agents in Field
|
|
* 2006 Reporting- Kandahar Supply Chain
|
|
* HUMINT
|
|
|
|
TOP SECRET//COMINT//REL
|
|
|
|
---
|
|
|
|
TOP SECRET//COMINT//REL
|
|
|
|
## (FOUO) Technical Considerations
|
|
|
|
* (TS//REL) Device
|
|
* Tiny, Embeddable Form Factor
|
|
* Very Low Power
|
|
* Non-Attributable Electronics
|
|
* (TS//REL) Communications
|
|
* Long Stand-Off Range, Covert
|
|
* (TS//REL) System
|
|
* Accuracy Despite Harsh Signal Environments
|
|
* Existing Infrastructure
|
|
* (TS//SI//REL) Alternatives
|
|
* RFID System: Sandia National Lab PAITS, LPS, RX
|
|
* Enabling Taggant: RX, ORNL
|
|
|
|
TOP SECRET//COMINT//REL
|
|
|
|
---
|
|
|
|
TOP SECRET//COMINT//REL
|
|
|
|
## (FOUO) Mechanics
|
|
|
|
* (TS//SI//REL) PAITS Long Range Tags
|
|
* Apply to Pharmaceuticals / Delivery System
|
|
* Where Repackaging not an Option
|
|
* Peritoneal Dialysis Solution- IV Bags
|
|
* E-Poetin Injection Bottles
|
|
* Native Tag Issues (RF Interference, Cover)
|
|
* Very High Probability Destination- HVI#1
|
|
* Intelligence / HUMINT Enabling
|
|
* Pharmaceutical Honey-Pot
|
|
* (TS//SI//REL) Gas Taggant Indicator
|
|
|
|
TOP SECRET//COMINT//REL
|
|
|
|
---
|
|
|
|
TOP SECRET//COMINT//REL
|
|
|
|
## (FOUO) Operation
|
|
|
|
* (TS//REL) Known Conduit: Pharma to Target
|
|
* (TS//SI//REL) Process
|
|
* Seal Broken for Pharmaceutical Use
|
|
* Gas Release/Detection
|
|
* Initiate RFID Tracking System
|
|
* (TS//SI//REL) GeoLocate Tags at Long Range
|
|
* (TS//REL) Independently Confirm Target Location
|
|
* (TS//REL) Initiate Operation on Acquired Target
|
|
|
|
TOP SECRET//COMINT//REL
|
|
|
|
---
|
|
|
|
UNCLASSIFIED//FOUO
|
|
|
|
## (U) Questions?
|
|
|
|
(FOUO) Contact Information:
|
|
|
|
* Dr. [REDACTED], SSG13 @nsa [REDACTED]
|
|
* [REDACTED], STDP / SSG13 @nsa [REDACTED]
|
|
|
|
UNCLASSIFIED//FOUO |